enVVeno Medical Corporation
NVNO
$10.53
$0.232.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.76% | -3.42% | -11.99% | 3.55% | 7.22% |
| Total Depreciation and Amortization | -7.39% | -8.52% | -8.38% | -7.62% | -3.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.46% | -0.91% | 6.66% | -8.10% | -11.95% |
| Change in Net Operating Assets | -236.55% | 103.61% | 216.71% | -2,244.44% | 147.08% |
| Cash from Operations | 7.54% | -3.14% | -2.83% | -0.04% | 10.71% |
| Capital Expenditure | 86.49% | 75.68% | 41.94% | 28.95% | -12.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,056.05% | 106.45% | 127.88% | 151.60% | 117.51% |
| Cash from Investing | 1,087.72% | 106.34% | 127.65% | 151.05% | 116.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -92.50% | -99.39% | -47.40% | -47.40% | -47.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -92.50% | -99.39% | -47.40% | -47.40% | -47.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 170.26% | -226.23% | 85.60% | 1,419.51% | -99.57% |